SCHEMBL31448604

SCHEMBL31448604

O=Cc1ccccc1Oc1cccc(Br)c1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.46
KMT2A Q03164 2/20 0.46
GAA P10253 1/20 0.46
ALDH1A1 P00352 6/20 0.45
MAPT P10636 3/20 0.45
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HPGD P15428 2/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ERN1 O75460 2/20 0.40
TLR2 O60603 2/20 0.39
TLR4 O00206 1/20 0.39
SRC P12931 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HSP90AA1 P07900 1/20 0.35
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31448636 0.85 HSPB1 (0.39) LMNAKMT2AGAAALDH1A1MAPT
SCHEMBL2625726 0.81 ERN1 (0.49) LMNAKMT2AALDH1A1MAPTERN1
SCHEMBL31448573 0.81 NPSR1 (0.43) LMNAKMT2AGAAALDH1A1MAPT
SCHEMBL31448419 0.80 KMT2A (0.41) LMNAKMT2AGAAALDH1A1MAPT
SCHEMBL24793679 0.79 LMNA (0.60) LMNAKMT2AGAAALDH1A1MAPT
SCHEMBL4111651 0.76 HPGD (0.60) LMNAKMT2AGAAALDH1A1MAPT
SCHEMBL31448487 0.75 P2RX3 (0.39) LMNAKMT2AGAAALDH1A1MAPT
SCHEMBL30772401 0.75 L3MBTL1 (0.35) GAAALDH1A1MAPTCYP1A2HPGD
SCHEMBL4434944 0.75 LMNA (0.75) LMNAKMT2AGAAALDH1A1MAPT
SCHEMBL7887959 0.74 HSPB1 (0.47) LMNAKMT2AGAAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361210-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND KISSEI PHARMACEUTICAL CO., LTD. (JP) 2025-11-27 US disclosed
EP-4512801-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND Kissei Pharmaceutical Co., Ltd. (JP) 2025-02-26 EP disclosed
CN-119343332-A 3, 4-Dihydro-quinolin-2 (1H) -one compounds 橘生药品工业株式会社 2025-01-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250361210-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND TSHR, TRHR, GHSR LMNA 4711/4885KMT2A 1876/4885GAA 3007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.